SGL Investment Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Sell
11,797
-118
-1% -$28.9K 0.89% 37
2025
Q4
$2.9M Buy
11,915
+213
+2% +$53.5K 1.16% 31
2025
Q3
$2.78M Buy
11,702
+343
+3% +$82.1K 1.16% 32
2025
Q2
$2.64M Buy
11,359
+138
+1% +$32.1K 1.26% 33
2025
Q1
$2.53M Sell
11,221
-88
-0.8% -$19.4K 1.31% 33
2024
Q4
$2.48M Buy
11,309
+360
+3% +$79K 1.25% 31
2024
Q3
$2.42M Buy
+10,949
New +$2.56M 1.24% 31

Other funds holding STE

SGL Investment Advisors's STE Position: Q1 2026 in Review

SGL Investment Advisors reduced its Steris (STE) stake by 0.99% in Q1 2026, selling an estimated $28.9K and leaving 11,797 shares worth $2.38M. The position accounts for 0.89% of the portfolio, ranked #37.

SGL Investment Advisors first reported a position in STE in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.9M in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • SGL Investment Advisors held 11,797 shares of Steris worth $2.38M as of Q1 2026.
  • SGL Investment Advisors sold 118 Steris shares in Q1 2026, an estimated $28.9K.
  • Steris made up 0.89% of SGL Investment Advisors's portfolio in Q1 2026, its #37 holding.
  • SGL Investment Advisors first reported a position in Steris in Q3 2024 and has held it in 7 quarters since.
  • SGL Investment Advisors's Steris position peaked at $2.9M in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.